Trials / Completed
CompletedNCT02050100
Biomarkers for Diagnosis of Lung Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- SK Medical (Beijing) Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study goal is to collect blood samples from individuals at risk for lung cancer in order to identify protein markers for diagnosis of lung cancer in the Chinese population.
Conditions
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-10-01
- Completion
- 2015-05-01
- First posted
- 2014-01-30
- Last updated
- 2017-05-12
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02050100. Inclusion in this directory is not an endorsement.